Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 4 (8th April 2022)

Record Type:: Journal Article
Title:: Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 4 (8th April 2022)
Main Title:: Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
Authors:: Kutsch, Nadine
Pallasch, Christian
Tausch, Eugen
Böhme, Volkmar
Ritgen, Matthias
Liersch, Rüdiger
Wacker, Alexander
Jacobs, Georg
Trappe, Ralf Ulrich
Dreger, Peter
Fischer, Kirsten
Fink, Anna-Maria
Stilgenbauer, Stephan
Zhai, Shuyan
Li, Biao
Jürgensmeier, Juliane M.
Rajakumaraswamy, Nishanthan
Bhargava, Pankaj
Hallek, Michael
Eichhorst, Barbara F.
Abstract:
Is Part Of:: HemaSphere. Volume 6:Issue 4(2022)
Journal:: HemaSphere
Issue:: Volume 6:Issue 4(2022)
Issue Display:: Volume 6, Issue 4 (2022)
Year:: 2022
Volume:: 6
Issue:: 4
Issue Sort Value:: 2022-0006-0004-0000
Page Start:: e692
Page End:
Publication Date:: 2022-04-08
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/HS9.0000000000000692 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21873.xml